Mangafodipir - Egetis Therapeutics
Alternative Names: mangafodipir trisodium; MnDPDP; PP-099; S 095; Teslascan; WIN 59010Latest Information Update: 12 Dec 2021
At a glance
- Originator GE Healthcare
- Developer GE Healthcare; PledPharma
- Class Acetates; Anti-ischaemics; Contrast media; Ethylenediamines; Pyridines; Small molecules
- Mechanism of Action Antioxidants; Iron chelating agents; Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Liver disorders
- Discontinued Myocardial infarction; Neutropenia